Complete Response to Encorafenib + Binimetinib in BRAF V600E-Mutant Tumor
October 29, 2024
This case report highlights the importance of full tumor genotyping to identify potentially actionable targets in rare tumors such as malignant glomus tumors.”BUFFALO, NY- October 29, 2024 – A new... read more